PE109898A1 - Nuevo uso de los derivados de benzopirano - Google Patents

Nuevo uso de los derivados de benzopirano

Info

Publication number
PE109898A1
PE109898A1 PE1997000831A PE00083197A PE109898A1 PE 109898 A1 PE109898 A1 PE 109898A1 PE 1997000831 A PE1997000831 A PE 1997000831A PE 00083197 A PE00083197 A PE 00083197A PE 109898 A1 PE109898 A1 PE 109898A1
Authority
PE
Peru
Prior art keywords
benzopiran
dimetil
diseases
new use
benzopyran derivatives
Prior art date
Application number
PE1997000831A
Other languages
English (en)
Inventor
Andrew A Parsons
Mervyn Thompson
Neil Upton
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of PE109898A1 publication Critical patent/PE109898A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE REFIERE AL USO DE ANTIHIPERTENSORES DE FORMULA (A) PARA EL TRATAMIENTO DE ENFERMEDADES DEGENERATIVAS (COMO COREA DE HUNTINGTON), DE TRANSTORNOS DEL SUENO, DE ENFERMEDADES DE LA NEURONA MOTORA, ENTRE OTROS, SIENDO PARTICULARMENTE UTILES PARA EL TRATAMIENTO DEL DOLOR NEUROPATICO Y DE LA NEURALGIA TRIGEMINA; EN DONDE, LOS COMPUESTOS DE FORMULA (A) PREFERIDOS SON: TRANS-6-ACETIL-4S-(4-FLUOROBENZOILAMINO)-3,4-DIHIDRO-2,2-DIMETIL-2H-1-BENZOPIRAN-3R-OL; CIS-6-ACETIL-4S-(3-CLORO-4-FLUOROBENZOILAMINO)-3,4-DIHIDRO-2,2-DIMETIL-2H-1-BENZOPIRAN-3S-OL; Y TRANS-6-ACETIL-4S-(3,5-DIFLUOROBENZOILAMINO)-3,4-DIHIDRO-2,2-DIMETIL-2H-1-BENZOPIRAN-3R-OL
PE1997000831A 1996-09-18 1997-09-18 Nuevo uso de los derivados de benzopirano PE109898A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9619492.3A GB9619492D0 (en) 1996-09-18 1996-09-18 Novel treatment

Publications (1)

Publication Number Publication Date
PE109898A1 true PE109898A1 (es) 1999-03-21

Family

ID=10800127

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1997000831A PE109898A1 (es) 1996-09-18 1997-09-18 Nuevo uso de los derivados de benzopirano

Country Status (30)

Country Link
EP (1) EP0939630B1 (es)
JP (1) JP2001500520A (es)
KR (1) KR20000036184A (es)
CN (1) CN1230885A (es)
AP (1) AP9901473A0 (es)
AR (1) AR008838A1 (es)
AT (1) ATE270102T1 (es)
AU (1) AU730465B2 (es)
BG (1) BG103252A (es)
BR (1) BR9712030A (es)
CA (1) CA2266681A1 (es)
DE (1) DE69729735T2 (es)
DZ (1) DZ2311A1 (es)
EA (1) EA199900306A1 (es)
ES (1) ES2223075T3 (es)
GB (1) GB9619492D0 (es)
HU (1) HUP9904638A3 (es)
ID (2) ID23175A (es)
IL (1) IL128786A0 (es)
MA (1) MA24321A1 (es)
NO (1) NO991292D0 (es)
NZ (1) NZ334271A (es)
OA (1) OA10998A (es)
PE (1) PE109898A1 (es)
PL (1) PL332313A1 (es)
SK (1) SK35199A3 (es)
TR (1) TR199900527T2 (es)
UY (1) UY24717A1 (es)
WO (1) WO1998011890A1 (es)
ZA (1) ZA978359B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7119214B2 (en) * 2004-04-13 2006-10-10 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
MX2010013313A (es) * 2008-06-05 2011-05-30 Minster Res Ltd Tratamientos novedosos.
WO2009147441A2 (en) * 2008-06-05 2009-12-10 Minster Research Limited Novel treatments
WO2011067607A1 (en) * 2009-12-03 2011-06-09 Minster Research Ltd Treatment of infectious diseases
CA2774715C (en) 2009-07-27 2018-04-03 Gilead Sciences, Inc. Fused heterocyclic compounds as ion channel modulators
US20130018091A1 (en) * 2009-12-03 2013-01-17 Peter Blower Treatment of allodynia and hyperalgesia
CN103096977B (zh) 2010-07-02 2017-02-15 吉利德科学公司 作为离子通道调节剂的稠杂环化合物
CA2834164A1 (en) 2011-05-10 2012-11-15 Gilead Sciences, Inc. Fused benzoxazinones as ion channel modulators
NO3175985T3 (es) 2011-07-01 2018-04-28
TWI478908B (zh) 2011-07-01 2015-04-01 Gilead Sciences Inc 作為離子通道調節劑之稠合雜環化合物
CN106397317B (zh) * 2016-09-26 2019-03-22 天津师范大学 1,2,3,4-四氢喹啉化合物及其合成方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment
US5510375A (en) * 1993-11-19 1996-04-23 Warner-Lambert Company Coumarin derivatives as protease inhibitors and antiviral agents
DE69524871T2 (de) * 1994-06-10 2002-08-22 Smithkline Beecham Plc Benzopyrans und deren verwendung als therapeutische mittel
GB9411635D0 (en) * 1994-06-10 1994-08-03 Smithkline Beecham Plc Novel treatment

Also Published As

Publication number Publication date
JP2001500520A (ja) 2001-01-16
ID23175A (id) 2000-03-23
EA199900306A1 (ru) 1999-08-26
GB9619492D0 (en) 1996-10-30
BG103252A (en) 1999-09-30
DZ2311A1 (fr) 2002-12-28
PL332313A1 (en) 1999-08-30
OA10998A (en) 2003-03-04
HUP9904638A2 (hu) 2001-05-28
BR9712030A (pt) 1999-08-24
AR008838A1 (es) 2000-02-23
EP0939630B1 (en) 2004-06-30
AU730465B2 (en) 2001-03-08
NZ334271A (en) 2001-03-30
DE69729735D1 (de) 2004-08-05
CN1230885A (zh) 1999-10-06
UY24717A1 (es) 2001-08-27
MA24321A1 (fr) 1998-04-01
IL128786A0 (en) 2000-01-31
AU4704797A (en) 1998-04-14
CA2266681A1 (en) 1998-03-26
HUP9904638A3 (en) 2001-08-28
TR199900527T2 (xx) 1999-06-21
NO991292L (no) 1999-03-17
KR20000036184A (ko) 2000-06-26
SK35199A3 (en) 2000-07-11
DE69729735T2 (de) 2005-07-14
ZA978359B (en) 1999-03-17
ID19542A (id) 1998-07-23
AP9901473A0 (en) 1999-03-31
EP0939630A1 (en) 1999-09-08
ES2223075T3 (es) 2005-02-16
ATE270102T1 (de) 2004-07-15
WO1998011890A1 (en) 1998-03-26
NO991292D0 (no) 1999-03-17

Similar Documents

Publication Publication Date Title
AR023727A1 (es) Compuestos empleados en el tratamiento de padecimientos inflamatorios
SV1999000016A (es) Derivados de 2-(purin-9-il-tetrahidrofuran-3,4-diol ref. pg3443/sv
SV1999000009A (es) Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol ref. pg3388/sv
ES2186015T3 (es) Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol.
PE109898A1 (es) Nuevo uso de los derivados de benzopirano
ES2100151T3 (es) Nuevos derivados de benzopirano, procedimientos para su preparacion y su uso y composiciones que contienen los compuestos.
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
ES2183331T3 (es) Inhibidores de sulfamida-metaloproteasa.
AR039667A2 (es) Procedimiento para la preparacion de la forma ii de 6-o-metileritromicina al vacio, dicho compuesto cristalino aislado asi como sus derivados, el uso de los mismos para la preparacion de un antibiotico, el uso de la forma 0 para preparar la forma ii de 6-o-metileritromicina a y otros derivados
ECSP055609A (es) "Uso de inhibidores de la IkB-quinasa para el tratamiento del dolor"
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
NO20021408D0 (no) Oksa- og tiadiazol-derivater anvendelige som antidiabetiske og antiovervektsmidler
NO20031001L (no) Polyarylkarboksamider nyttige som lipidsenkende midler
AR008861A1 (es) COMPUESTOS DE LACTAMA E IMIDA HETEROCICLICOS DE ARALQUILO Y ARALQUILEDENO, COMPUESTOS INTERMEDIARIOS PARA SU SíNTESIS, COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN.
BR9711319B1 (pt) derivados de camptotecina altamente lipofìlicos.
ES2157683T3 (es) 4-hidroxiindoles cationicos y su utilizacion para el teñido por oxidacion de las fibras queratinicas.
AR001813A1 (es) Derivados de cromona procedimiento para prepararlos y las composiciones farmacéutica que los contienen
AR028743A1 (es) DERIVADOS DE N-TRIAZOLILMETIL-PIPERAZINA CON ACCIoN ANTAGONISTA DE RECEPTORES DE NEUROQUININA
ECSP034530A (es) Derivados de 6-metil-tramadol sustituido en o
ES2170846T3 (es) Composiciones cosmeticas con filtros solares.
ES2166026T3 (es) Derivados de 1,2,3-benzotiadiazol y su uso como microbicidas.
BG106016A (en) Resorcinol derivatives
ES2162686T3 (es) Nuevos derivados carboxamidas ciclicos sustituidos por carboxi.
DE69703115D1 (de) Zwischenprodukte um 2-imidazolin-5onederivate herzustellen.
AR008616A1 (es) Uso de derivados de fluo-antraciclinona y fluo-antraciclina.

Legal Events

Date Code Title Description
FC Refusal